Natixis Ptc Therapeutics, Inc. Transaction History

Natixis

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $1.05 Million - $1.35 Million	25,000 New	25,000 $1.26 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $4 Million - $4.73 Million	-113,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $3.62 Million - $4.38 Million	-97,892 Reduced 46.42%	113,000 $4.21 Million
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $9.87 Million - $14.5 Million	210,892 New	210,892 $9.99 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.